Peter Belden Named General Manager of PCI Rockford Facilities
News Sep 02, 2013
Packaging Coordinators, Inc. (PCI) has announced that Peter Belden has assumed the role of General Manager for its Rockford, IL based facilities.
PCI operates nine facilities in Rockford, totaling over 1,000,000 square feet and employing over 1,300 highly trained associates.
The site supports pharmaceutical and biotech packaging services for clinical and commercial medicines, as well as medical device, and consumer healthcare products.
PCI is headquartered in Philadelphia, PA and features over 14 facilities in North America and Europe serving the global pharmaceutical packaging market.
The company added the Rockford facilities as part of its acquisition of AndersonBrecon Inc. from AmerisourceBergen Corporation in May of this year.
Having previously held Senior Vice President of Sales and Marketing position at the Rockford site as well as having headed the PCI operations in Hay-on-Wye, Wales in the United Kingdom, Belden enters his new role as General Manager in Rockford, bringing over 25 years of experience in the packaging industry.
“We are very excited to have Pete in this role” states Bill Bolding, Chief Operating Officer at PCI. “Pete brings a wealth of experience and truly understands the needs of our customers. His personal commitment to customer satisfaction underscores the company’s focus on true strategic partnership and bringing value to our clients as an extension of their business. Pete’s demonstrated leadership has him well positioned to lead the Rockford team.”
PCI has recently announced substantial investment in the Rockford sites, including the addition of multiple new high speed blistering and bottling lines to support business growth.
Other notable capital investments include the expansion of Cold Chain storage, bringing the company’s Rockford capacity to over 1,000 pallet spaces of 2 - 8°C in support of its rapidly expanding business for Biotech products and parenteral delivery forms.
The European site in Hay features four facilities supporting clinical and commercial packaging for pharmaceutical and biotech products, as well as global distribution of clinical trial materials.
PhoreMost and Plexxikon Collaborate to Identify Novel Drug TargetsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, today announced it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018